Get the Stockscreener App
9.54
1.65%
-0.16
After Hours:
9.54
Arcus Biosciences Inc Stock (RCUS) Latest News
Arcus Biosciences at Barclays Conference: Strategic Pipeline Insights By Investing.com - Investing.com UK
Top 10 Insider Purchases Last Month - Insider Monkey
(RCUS) Investment Analysis - Stock Traders Daily
Arcus Biosciences at Leerink’s Global Healthcare Conference: Strategic Advancements By Investing.com - Investing.com Canada
RCUS stock touches 52-week low at $9.42 amid market challenges - Investing.com Australia
Terry Rosen Increases Stake in Arcus Biosciences Inc (RCUS) with Recent Share Purchase - GuruFocus.com
Little Excitement Around Arcus Biosciences, Inc.'s (NYSE:RCUS) Revenues As Shares Take 26% Pounding - Simply Wall St
Arcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Insider Buying: Arcus Biosciences Co-Founder Bought US$201k Of Shares - Yahoo Canada Finance
Learn to Evaluate (RCUS) using the Charts - Stock Traders Daily
Arcus Biosciences (NYSE:RCUS) Upgraded at HC Wainwright - Defense World
Wedbush Forecasts Arcus Biosciences’ Q1 Earnings (NYSE:RCUS) - Defense World
Arcus Biosciences director Yasunori Kaneko buys $201,200 in shares By Investing.com - Investing.com South Africa
Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance UK
What is Leerink Partnrs’ Forecast for RCUS Q1 Earnings? - Defense World
RCUS stock touches 52-week low at $9.88 amid market challenges - Investing.com Australia
Arcus Biosciences CEO Terry J. Rosen buys $201,465 in common stock - Investing.com Australia
Arcus Biosciences CEO Terry J. Rosen buys $201,465 in common stock By Investing.com - Investing.com South Africa
Arcus Biosciences director Yasunori Kaneko buys $201,200 in shares - Investing.com India
Arcus Biosciences Executives Increase Their Holdings - TradingView
RCUS stock touches 52-week low at $9.88 amid market challenges By Investing.com - Investing.com South Africa
Arcus Biosciences’ SWOT analysis: promising pipeline drives stock outlook By Investing.com - Investing.com South Africa
HC Wainwright & Co. Upgrades Arcus Biosciences (RCUS) - Nasdaq
Can Arcus Biosciences Reveal New Cancer Pipeline Updates at March Healthcare Conferences? - StockTitan
Arcus Biosciences' SWOT analysis: promising pipeline drives stock outlook - Investing.com
Arcus Biosciences’ SWOT analysis: promising pipeline drives stock outlook - Investing.com India
Arcus Biosciences gains after H.C. Wainwright upgrades to "buy" - TradingView
HC Wainwright Upgrades Arcus Biosciences to Buy From Neutral, Adjusts Price Target to $24 From $18 - Marketscreener.com
Arcus Biosciences stock rating upgraded to Buy at H.C. Wainwright By Investing.com - Investing.com UK
Arcus Biosciences Reports 2024 Financial Results and Pipeline Progress - TipRanks
Arcus Biosciences reports Q4 EPS ($1.03), consensus ($1.20) - TipRanks
Arcus Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Arcus Biosciences earnings beat by $0.20, revenue topped estimates - Investing.com Canada
Arcus Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings Flash (RCUS) Arcus Biosciences Posts Q4 Revenue $36M, vs. FactSet Est of $29.3M - Marketscreener.com
Can Arcus Biosciences' Promising Cancer Drug Results Transform Kidney Cancer Treatment? - StockTitan
Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Kno - GuruFocus.com
Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Inside Arcus Biosciences' Latest Executive Compensation Package: Key Numbers Revealed - StockTitan
Arcus Biosciences Announces New Employment Inducement Grants - The Bakersfield Californian
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Sold by New York State Teachers Retirement System - Defense World
Arcus Biosciences Inc expected to post a loss of $1.25 a shareEarnings Preview - TradingView
First Week of October 17th Options Trading For Arcus Biosciences (RCUS) - Nasdaq
What is HC Wainwright’s Forecast for RCUS Q1 Earnings? - Defense World
Arcus Biosciences, Inc. (NYSE:RCUS) Receives $31.29 Consensus Target Price from Analysts - Defense World
Arcus Biosciences appoints new Chief Medical Officer - MSN
Gilead Sciences acquires $14.9 million in Arcus Biosciences stock By Investing.com - Investing.com South Africa
Gilead Sciences acquires $14.9 million in Arcus Biosciences stock - Investing.com
Arcus Biosciences stock hits 52-week low at $10.65 By Investing.com - Investing.com Nigeria
Arcus Biosciences stock hits 52-week low at $10.65 - Investing.com India
These Analysts Just Made A Decent Downgrade To Their Arcus Biosciences, Inc. (NYSE:RCUS) EPS Forecasts - Yahoo Finance
Arcus Biosciences stock dips after pricing $150M offering - MSN
Latham & Watkins Advises Arcus Biosciences in US$150 Million Offering of Common Stock - Legal Desire News Network
Arcus Biosciences stock target cut to $18 at H.C. Wainwright By Investing.com - Investing.com Nigeria
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):